(2024). Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control study. Bmc Pulm Med, 24, 221. http://doi.org/10.1186/s12890-024-03035-4
. Atrial fibrillation
(2024). Effectiveness and Safety of Edoxaban Compared With Apixaban in Elderly Patients With Nonvalvular Atrial Fibrillation: A Real-World Population-Based Cohort Study. Stroke. http://doi.org/10.1161/strokeaha.123.045098
. (2024). Initiation patterns of anticoagulants for atrial fibrillation among older UK adults with and without chronic kidney disease, 2010-2020. Open Heart, 11. http://doi.org/10.1136/openhrt-2023-002515
. (2023). Oral anticoagulant prescribing among patients with cancer and atrial fibrillation in England, 2009-2019. Cancer. http://doi.org/10.1002/cncr.35152
. (2023). Common Cancer Types and Risk of Stroke and Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Study in England. J Am Heart Assoc, 12, e029423. http://doi.org/10.1161/jaha.123.029423
. (2023). Optimising prediction of mortality, stroke, and major bleeding for patients with atrial fibrillation: validation of the GARFIELD-AF tool in UK primary care electronic records. Br J Gen Pract, 73, e816-e824. http://doi.org/10.3399/bjgp.2023.0082
. (2023). Temporal trends of cause-specific mortality after diagnosis of atrial fibrillation. Eur Heart J. http://doi.org/10.1093/eurheartj/ehad571
. (2023). Progression of stroke risk in patients aged <65 years diagnosed with atrial fibrillation: a cohort study in general practice. Br J Gen Pract. http://doi.org/10.3399/bjgp.2022.0568
. (2023). Incident cardiovascular, renal, metabolic diseases and death in individuals identified for risk-guided atrial fibrillation screening: a nationwide cohort study. Open Heart, 10. http://doi.org/10.1136/openhrt-2023-002357
. (2023). Prediction of short-term atrial fibrillation risk using primary care electronic health records. Heart. http://doi.org/10.1136/heartjnl-2022-322076
.